Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:ETrE(5Z,8Z,11Z))

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001144 AN001887 Microbial depletion and ozone exposure - serum (part II) Blood Mouse Asthma Harvard School of Public Health Area under curve
ST002457 AN004009 Mouse kidney metabolomics (Whole kidney) Kidney Mouse Chronic kidney disease Hadassah Medical Center concentration
ST001403 AN002345 Ontogeny related changes in the pediatric liver metabolome (part-II) Liver Human Moffitt Cancer Center estimated abundances
ST002555 AN004207 Ethnicity-Specific Differences in Ovarian Cancer Metabolic Signatures Cultured cells Human Cancer University of Oklahoma Health Sciences Center Fold change over standard
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham Women's Hospital intensity
ST002797 AN004550 Fetal metabolic adaptations to cardiovascular stress in twin-twin transfusion syndrome Amniotic fluid Human Twin-twin transfusion syndrome University of Texas Health Science Center at Houston intensity
ST002149 AN003519 In vivo commensal control of Clostridioides difficile virulence Cecum Mouse Brigham and Women’s Hospital Intensity
ST002829 AN004621 Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study Blood Human COVID-19 National Institutes of Health log transformed data
ST002354 AN003842 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health mg/g tissue
ST002354 AN003842 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health mg/g tissue
ST002354 AN003844 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health mg/mL
ST002354 AN003844 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health mg/mL
ST000916 AN001491 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS nM
ST000917 AN001497 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS nM
ST001866 AN003028 Systemic metabolite changes due to PHD inhibition Blood Mouse Northwestern University Peak
ST000260 AN000414 Analysis of DJ-1 Knockout Mouse Brains Brain Mouse National Insitute on Aging Peak area
ST001157 AN001915 The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) Blood Mouse Johns Hopkins University School of Medicine Peak area
ST001158 AN001916 The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) Feces Mouse Johns Hopkins University School of Medicine Peak area
ST001218 AN002031 Wild type versus TRACK Mice on regular chow and Vitamin A deprived diet Kidney Mouse Cancer weill cornell medicine Peak area
ST002754 AN004470 Metabolomics analysis of maternal obesity model Blood Mouse Fatty liver disease University of Bonn Peak Area
ST000890 AN001452 Identification of RXR Ligands Blood Mouse Washington University School of Medicine Peak area ratio
ST000352 AN000573 Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease Brain Mouse Krabbe disease University at Buffalo Peak height
ST000451 AN000707 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data Muscle Mouse University of North Carolina Peak values (scaled)
ST000452 AN000708 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data Blood Mouse University of North Carolina Peak values (scaled)
ST001827 AN002963 The pregnancy metabolome from a multi-ethnic pregnancy cohort Blood Human Icahn School of Medicine at Mount Sinai pmoles/l
ST000915 AN001485 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS pmol/mg
ST001983 AN003234 Metabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell Lines Ovarian cancer cells Human Cancer University of Oklahoma Health Sciences Center ratio
ST000899 AN001464 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center raw area counts
ST001404 AN002346 Ontogeny related changes in the pediatric liver metabolome (part-III) Liver Human Moffitt Cancer Center Relative Abundance
ST001870 AN003032 Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats Heart Rat University of Minnesota relative value
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST002018 AN003288 Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) Feces Human Vanderbilt University Medical Center scaled imputed
ST002019 AN003289 TIPs Metabolomics (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST000976 AN001597 GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST000815 AN001292 db/db WT ozone and air exposed mice Lung Mouse Ozone Stress Harvard School of Public Health total ion counts
ST000093 AN000149 Metabolomics Analysis of Frontal Fibrosing Alopecia Scalp Human Alopecia Case Western Reserve University Unspecified
ST001253 AN002081 Phenotyping Mouse blood metabolites in day and night in type 2 diabetes Blood Mouse Diabetes Indiana University School of Medicine VolNormImp Area counts
  logo